Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
    Journal Article

    Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; King, A. C.; Rampal, R. K.; Tallman, M. S.; Park, J. H.; Douer, D.
    Leukemia Research (2016)

    Fulltext@MSK | Save
  • Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
    Journal Article

    Verstovsek, S.; Manshouri, T.; Pilling, D.; Bueso-Ramos, C. E.; Newberry, K. J.; Prijic, S.; Knez, L.; Bozinovic, K.; Harris, D. M.; Spaeth, E. L.; more...
    Journal of Experimental Medicine (2016)

    Fulltext@MSK | Save
  • Comparison of pace clinical trial vs real-world ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Preliminary findings from a chart review of lower dosing of ponatinib in chronic myeloid leukemia (CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L.; Inguilizian, A.; du Moulin, R.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Characteristics of ponatinib therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) patients in real-world clinical practice compared to the pace trial
    Meeting Abstract

    Mauro, M.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Very young patients with chronic lymphocytic leukemia have lower incidence of adverse cytogenetics and improved overall survival: 10-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Devlin, S.; Park, J.; Tallman, M.; Berman, E.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Impact of disease burden on long-term outcome of CD19-targeted CAR modified T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Sadelain, M.; Brentjens, R.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Sgn-CD33A in combination with hypomethylating agents: A novel, well-tolerated regimen with high remission rate in older patients with AML
    Meeting Abstract

    Fathi, A.; Erba, H.; Lancet, J.; Stein, E.; Ravandi, F.; Faderl, S.; Walter, R.; Advani, A.; DeAngelo, D.; Kovacsovics, T.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Safety study of crenolanib, a Type I FLT3 inhibitor, with cytarabine/daunorubicin or cytarabine/idarubicin induction and high-dose cytarabine consolidation in newly diagnosed FLT3+ AML
    Meeting Abstract

    Wang, E.; Stone, R.; Tallman, M.; Thompson, J.; Ontiveros, E.; Olson, G.; Galinsky, I.; Pond, B.; Uchida, A.; Urity, V.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Clinical response in relapsed/refractory AML patients correlates with leukemic blast mobilization and differentiation induced by BL-8040, a potent CXCR4 antagonist; Results of a phase IIA study
    Meeting Abstract

    Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J. K.; more...
    Haematologica (2016)

    Fulltext@MSK | Save